Please login to the form below

Not currently logged in
Email:
Password:

Tiziana Life Sciences appoints clinical sciences VP

Dr Robert Evans joins the UK biotechnology firm

London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences.

Dr Evans joins the clinical stage biotechnology company from Glenmark Pharmaceuticals, where he also served as vice president of clinical sciences.

In that role, he was responsible for providing project and clinical leadership across multiple programmes focused on the treatment of oncology, respiratory and dermatology disorders.

Prior to this, Dr Evans held a number of scientific leadership positions while at Amgen, Johnson & Johnson and Regeneron.

James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive background in the clinical development industry… combined with his strong background in immunology and oncology adds tremendous support to our exciting portfolio.

“I am very confident that together with out impressive pipeline and strong team we will continue to drive the company forward to significant future success.”

6th May 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics